Navigation Links
Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
Date:1/3/2008

SHANGHAI, China, Jan. 3 /PRNewswire/ -- Cinpathogen, through its partnership in the Fudan-Cinpathogen Clinical and Molecular Research Center, has begun offering clinical diagnostic technology consulting services to Shanghai area hospitals. For the past four years as part of the Shanghai Health Study, the Center has diagnosed and characterized over 3000 cases of hematopoietic and lymphoid diseases in collaboration with area hospitals and colleagues at Fudan University, the University of Colorado at Denver and Health Sciences Center and the University of Cincinnati. By launching this service, Cinapthogen and the Institute of Biomedical Sciences at Fudan University are ensuring continuous development and enhancement of the clinical diagnostic capabilities in China.

"Though the research project has made a solid landing after seven years of extensive effort and participation, the Fudan-Cinpathogen Clinical and Molecular Research Center's mission will continue," said Professor Ouyang Renrong, former chairman of the Chinese Hematology and the Shanghai Hematology Societies. "The center, led by Dr. Richard Irons, will continue its journey in China to provide clinical services and research efforts in the field of hematology."

China is making research and development a priority and this move is aligned with the recent meeting of China's 17th Party Congress where continued scientific innovation was a major theme.

Cinpathogen is a major partner in the Fudan-Cinpathogen Clinical and Molecular Research Center at the Institutes of Biomedical Sciences at Fudan University, integrating basic and clinical research, modern diagnostic laboratories and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems.

If you'd like more information about this topic or Cinpathogen, please contact Dr. Richard D. Irons at (303) 381-2543 or email him at contact@cinpathogen.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Cinpathogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
2. CardioDynamics Provides 2007 Shareholder Meeting Update
3. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
4. NxStage Medical Provides Update on Medisystems Acquisition
5. VaxGen Files 2006 Financial Statements and Provides Cash Update
6. Signalife Provides Corporate Update
7. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
8. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
9. SGX Provides Update on BCR-ABL Collaboration
10. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
11. Pressure BioSciences, Inc. Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , December 8, 2016 Oxford ... its customisable SureSeq™ NGS panel range with the launch of ... and cost-effective study of variants in familial hypercholesterolemia (FH). The ... (CNV) detection on a single small panel and allows customisation ... This includes all exons for LDLR , P ...
(Date:12/8/2016)... Worcester, Mass (PRWEB) , ... December 08, 2016 ... ... KbioBox genetic data bioInformatics portal. In response to client demand KbioBox developed a ... gene edit biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... ... 08, 2016 , ... Microbial genomics leader, uBiome, joins Google, ... of just six company finalists in the Health & Medicine category. Over 1,000 ... as finalists in this year’s awards include Google, SpaceX, Oculus, and SolarCity. Individuals ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
Breaking Biology News(10 mins):